The anti-obesity effect of namodenoson, an A3 adenosine receptor agonist.

Fishman P, Itzhak I, Safadi R, Amer J, Salhab A, Bareket-Samish A

Open source

DOI
10.1038/s41366-026-02017-2
Published
2026 Apr
Container
International journal of obesity (2005)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41366-026-02017-2,
  title = {The anti-obesity effect of namodenoson, an A3 adenosine receptor agonist.},
  author = {Fishman P and Itzhak I and Safadi R and Amer J and Salhab A and Bareket-Samish A},
  year = {2026},
  journal = {International journal of obesity (2005)},
  doi = {10.1038/s41366-026-02017-2},
  url = {https://doi.org/10.1038/s41366-026-02017-2}
}

RIS

TY  - JOUR
TI  - The anti-obesity effect of namodenoson, an A3 adenosine receptor agonist.
AU  - Fishman P
AU  - Itzhak I
AU  - Safadi R
AU  - Amer J
AU  - Salhab A
AU  - Bareket-Samish A
PY  - 2026
JO  - International journal of obesity (2005)
DO  - 10.1038/s41366-026-02017-2
UR  - https://doi.org/10.1038/s41366-026-02017-2
ER  - 

APA

P, F., I, I., R, S., J, A., A, S., & A, B. (2026). The anti-obesity effect of namodenoson, an A3 adenosine receptor agonist.. International journal of obesity (2005). https://doi.org/10.1038/s41366-026-02017-2

Source records